HANNAH HENSON: Open Payments
NPI 1053968297 · SEYMOUR, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,526 in 94 payments from 14 companies in 2025. Trend: 2023 $1,802 · 2024 $1,704 · 2025 $1,526
Food & beverage: $1,524Education: $2
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $406 |
| Alkermes, Inc. | 20 | $364 |
| Vanda Pharmaceuticals Inc. | 19 | $288 |
| E.R. Squibb & Sons, L.L.C. | 5 | $78 |
| Collegium Pharmaceutical, Inc. | 4 | $77 |
| Otsuka America Pharmaceutical, Inc. | 4 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Corium, LLC | 2 | $37 |
| Lundbeck LLC | 2 | $34 |
Products named: VRAYLAR, ARISTADA, FANAPT, REXULTI, COBENFY, Jornay PM, CAPLYTA, TRINTELLIX.
Industry payments across IN — which companies pay providers there.
